ClinicalTrialsFinder

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma Clinical Trials in Shanghai, Shanghai Municipality

1 recruitingShanghai, Shanghai Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
Aibin Liang，MD，Ph.D.48 enrolled1 locationNCT05842707